For example, EZH2 can affect CD8+ T cell-mediated anti-tumor immunity by regulating the expression of Th-1 chemokines [22, 23] or the infiltration of myeloid-derived suppressor cells (MDSCs) [24, 25]. The gene discussed is EZH2; the disease is neoplasm.